Impotency is not a disease; it is a curable condition which can be treated easily. In earlier times, it was bit difficult to cure it completely. But the growing medical field and technology has made everything possible. There are many kinds of impotency drugs and treatments available in market today. It is very important to choose the one that is effective and safer.

The medical researches still keep on introducing more impotency drugs with more benefits and lesser side effects. Uprima is one of the latest impotency drugs that are under observation to get the approval of FDA. TAP pharmaceuticals are the manufacturers of the drug which mainly focuses on the treatment of erectile dysfunction.

The experts claim the power and benefits of uprima similar to that of Viagra, which is today’s most popular male enhancement pill. This new impotency drug works by stimulating brain for the production of a chemical named, dopamine.

One of the drawbacks of the medication is that it leaves the chance of two side effects, nausea and hypotension. But the advantage is that the product works similar to Viagra and also faster than it. The way of taking the medicine is something different; the pill needs to be dissolved under the tongue so that the medicine is absorbed easily into the blood stream.

Another unique advantage compared to Viagra is the response time. Uprima takes only 15 to 20 minutes to expose the results whereas Viagra takes about an hour to work. A diagnosis prior to the treatment is an additional advantage of the pill. This helps to determine the correct cause for impotency and treat accordingly.

The medical world is waiting for more test results so that they can decide whether to approve or not and introduce the new impotency drug to the world so that it can help more impotent males.

 Leave a Reply

(required)

(required)

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
© 2011 | Home Privacy Policy | RSS Feed | Sitemap Suffusion theme by Sayontan Sinha